As of 2026-04-12, the Relative Valuation of AnaptysBio Inc (ANAB) is (8.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 70.10 USD, the upside of AnaptysBio Inc based on Relative Valuation is -112.2%.
The range of the Relative Valuation is (7.80) - (9.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 21.1x | 19.0x |
| Forward P/E multiples | 15.5x - 21.0x | 18.3x |
| Fair Price | (7.80) - (9.65) | (8.57) |
| Upside | -111.1% - -113.8% | -112.2% |
| Date | P/E |
| 2026-04-10 | -152.31 |
| 2026-04-09 | -148.92 |
| 2026-04-08 | -142.40 |
| 2026-04-07 | -134.99 |
| 2026-04-06 | -135.65 |
| 2026-04-02 | -125.32 |
| 2026-04-01 | -123.26 |
| 2026-03-31 | -120.50 |
| 2026-03-30 | -120.35 |
| 2026-03-27 | -124.72 |
| 2026-03-26 | -141.21 |
| 2026-03-25 | -142.08 |
| 2026-03-24 | -136.93 |
| 2026-03-23 | -136.28 |
| 2026-03-20 | -135.50 |
| 2026-03-19 | -140.62 |
| 2026-03-18 | -140.62 |
| 2026-03-17 | -146.21 |
| 2026-03-16 | -140.75 |
| 2026-03-13 | -140.82 |
| 2026-03-12 | -138.60 |
| 2026-03-11 | -140.51 |
| 2026-03-10 | -134.73 |
| 2026-03-09 | -129.71 |
| 2026-03-06 | -120.39 |
| 2026-03-05 | -124.46 |
| 2026-03-04 | -131.56 |
| 2026-03-03 | -114.79 |
| 2026-03-02 | -119.31 |
| 2026-02-27 | -119.61 |
| 2026-02-26 | -121.91 |
| 2026-02-25 | -119.74 |
| 2026-02-24 | -120.39 |
| 2026-02-23 | -117.96 |
| 2026-02-20 | -117.74 |
| 2026-02-19 | -120.50 |
| 2026-02-18 | -119.13 |
| 2026-02-17 | -116.67 |
| 2026-02-13 | -115.33 |
| 2026-02-12 | -119.28 |
| 2026-02-11 | -120.05 |
| 2026-02-10 | -109.16 |
| 2026-02-09 | -108.53 |
| 2026-02-06 | -108.05 |
| 2026-02-05 | -104.08 |
| 2026-02-04 | -105.12 |
| 2026-02-03 | -111.27 |
| 2026-02-02 | -109.81 |
| 2026-01-30 | -103.01 |
| 2026-01-29 | -103.97 |